Cetero executives seek bonuses as company looks for new owners; Amgen buys KAI for $315M;

> An affiliate of private investment firm Sun Capital Partners has acquired CornerStone Research & Development, a leading manufacturer in the vitamin and dietary supplement market. Release

> Amgen ($AMGN) forks over $315 million to purchase KAI Pharmaceuticals. Article

> A group of Cetero Research executives are seeking court permission for a $1.3 million bonus on the sale of the company. Article

> Theorem Clinical Research announces that Nitin Jain will assume the role of vice president and general manager of Theorem's Asia-Pacific region. Release

Suggested Articles

Clinerion has penned a deal to tap Wefight’s so-called Vik app to help seek out patients and play matchmaker for them to join clinical trials.

Icon is boosting its medical device and diagnostic research offering with a buyout deal for Parisian medtech CRO MedPass International.

California clinical trial artificial intelligence startup Saama Technologies has teamed up with Big Pharma Pfizer.